http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012107294-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12d54271c3d8aa97e740f61aec2521a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
filingDate 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_876c13aeec8b88c602012f35417aaf17
publicationDate 2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012107294-A1
titleOfInvention Composition for in vivo transplantation for treatment of human cervical cancer comprising mononuclear cells derived from umblical cord blood
abstract Provided is a composition for in vivo transplantation for the treatment of human cervical cancer, comprising mononuclear cells derived from umbilical cord blood and a pharmaceutically acceptable carrier. When the umbilical cord blood-derived mononuclear cells are transplanted in vivo, cervical cancer can be effectively treated. In particular, the mononuclear cells derived from the umbilical cord blood retain high differentiation and proliferation abilities and exhibit very low graft-versus-host (GVH) reactions which are side effects caused by transplantation, and thus, can be transplanted to many patients.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9144555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662302-B2
priorityDate 2006-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005058622-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505865
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53320

Total number of triples: 33.